MIRA
INFORM REPORT
|
Report Date : |
20.02.2008 |
IDENTIFICATION
DETAILS
|
Name : |
SOBHAN DAROU CO |
|
|
|
|
Registered Office : |
No.288, Fatemi Ave, Tehran |
|
|
|
|
Country : |
Iran |
|
|
|
|
Financials (as on) : |
29.03.2006 |
|
|
|
|
Date of Incorporation : |
1977 |
|
|
|
|
Com. Reg. No.: |
25673 |
|
|
|
|
Legal Form : |
Public Joint
Stock Company |
|
|
|
|
Line of Business : |
Production of Pharmaceutical Preparations for the Cardiovascular System,
Central and Autonomic Nervous System |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Company
Details
Company Name: Sobhan
Darou Co
Headquarter Address: No. 288, Fatemi
Ave
Tehran
Iran
Tel:
+98 21 66912686
+98 21 66912687
+98 21 66912688
+98 21 66912156
Fax:
+98 21 66948545
Website: www.sobhanpharma.com
E-mail: info@sobhanpharma.com
Registration
& Legal Details
Current Legal Form: Public Joint Stock Company
Registration Address: No.288, Fatemi Ave
Tehran
Iran
Registration Number: 25673
Registration Date: 1977
Year Established: 1977
Registration Town: Tehran
Capital
Currency: Iranian Rials
Nominal capital: 172,800,000,000
|
Number of Shares: 172,800,000 |
Type of Shares: None Selected |
|
Issued Shares: - |
Value per share: IRI 1,000.00 |
Shareholders
|
Shareholder Names/ Address |
% of Voting/Non-Voting Capital |
|
Alborz Investment Tehran Iran |
%20 |
|
Tooli Pers
Company Tehran Iran |
%30 |
|
Keyvan Company Tehran Iran |
%12 |
|
Others Iran |
%21 |
|
Tolidarou
Company Tehran Iran |
%17 |
Principals
Name:
Mr. Mohamd Ismaeil
Akbari
Position within the
company: Chairman
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi- English
Name:
Mr. Mohsen Sanei
Position within the
company:
Member
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi, English
Name:
Mr. Hamid Reza Jamshidi
Position within the
company:
Managing Director
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi, English
Name:
Mr. Seyed Hashem
Tabrizi Dana
Position within the company: Member
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi, English
Name:
Mr. Morteza Azarnoosh
Position within the
company: Vice Chairman
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi- English
Company
Activities
Production of:
Pharmaceutical preparations for the cardiovascular system, central and
autonomic nervous system
Pharmaceutical preparations for metabolism, nutrition, alimentary
systems. Pharmaceutical preparations for urology, dermatology, gynaecology and
obstetrics
Chemotherapeutic agents, endocrines,
antiseptics, immunological preparations
Local Reporters consider the investigated company to be
Large their field of concern.
Operations
Employees
Company Employs:
685
HQ Premises
Operates from: Owned Offices, Warehouses,
Factory
Location: Central Business Area,
Main Road
Imports
Import%:
20% Raw Material, 10% Finished Good
Import from: Western Europe
Import terms: letters of credit
Additional:
balance of 70% purchased via local market
Export
Exports: Finished
Goods
Export%: 40%
Export to: Persian Gulf
Countries, CIS, Afghanistan
Export terms: letters of credit
Trading
& Selling
Territory: 60%
Nationality, 40 % Internationally
Type of Customer: General Public,
Local Authorities
Terms of sales: Cash, letters of credit
Vehicles: Total number of vehicles: 90
Related
Companies
Subsidiaries:
Swiran Company
5th floor, No. 8, Eftekharinia St., Valiasr Ave.,
Tehran 15956,
Iran
Tel: 0098-21-88916848
Fax: 0098-21-88916849
E-mail: info@swiran.com
Affiliates:
Tolid Daru Co
Shahid Yadegar St, Saveh Road, serah Azari
Area
Tehran
Iran
Tel: +98 21 66705119
Fax: +98 21 66704390
Website: www.tolidaru.com
E-mail: info@tolidaru.com
Iran Darou Company
Tehran
Iran
Alborz Darou Co
4nd Floor, Alborz Bldg, No.56, Khaled
Eslamboli(Vozara) St
Beheshti Ave
Tehran
Iran
Tel: +98 21 88722434
Fax:+98 21 88721516
Website: www.alborzdarouco.com
E-mail: info@alborzdarouco.com
Banks
Bank Saderat
Tehran
Iran
Bank Melli
Tehran
Iran
Bank Sepah
Tehran
Iran
Financial Information
Source: Ms. Sabeti (Secretary)
Currency: Iranian Rials -
000,000
|
Months |
Date |
Sales |
Gross
|
Net |
|
12 |
29/03/2007 |
1065010 |
198036 |
131840 |
|
12 |
29/03/2006 |
1414360 |
268612 |
191860 |
|
12 |
29/03/2005 |
931491 |
219070 |
165080 |
BALANCE
SHEET
Source: Financial Estimates on
29/03/2006
Currency: Iranian Rials
Note: Figures in 000,000
|
NEW WORTH |
166100 |
|
Trade Creditor |
101400 |
|
Total Liabilities |
172000 |
|
|
|
|
Trade Debtors |
92500 |
|
Total Assets |
347000 |
Payments
Subject's payments reported to be: NO COMPLAINTS
interview
& reporter comments
Name/Title: Ms. Sabeti (Secretary)
In the interview conducted with Ms. Sabeti (Secretary), she declined bank account numbers citing the grounds of Company
confidentiality.
Conclusion
Local Reputation: The company being investigated is considered by local reporters to be a
Normal Trade Risk.
General Conclusion:
Local informants consider granting of credit to be a fair trade risk.
Owner/Shareholders Comments:
Some of owners involved in the running of
the business
Age of Business: Old
Business
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)